Genzyme ^Investors

Genzyme Corporation is a biotechnology company that focuses on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant, and immune disease. The company operates in four business segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery, and Hematologic Oncology. Genzyme's Genetic Diseases unit develops and distributes therapeutic products for patients with genetic diseases, including lysosomal storage disorders. The Cardiometabolic and Renal segment focuses on treating renal diseases, chronic renal failure, and endocrine and cardiovascular diseases. The Biosurgery segment develops and distributes biotherapeutics and biomaterial-based products, while the Hematologic Oncology segment focuses on cancer treatment.